| Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine … P Chang, KM Szymanski, RL Dunn, JJ Chipman, MS Litwin, PL Nguyen, ... The Journal of urology 186 (3), 865-872, 2011 | 190 | 2011 |
| tableone: create “Table 1” to describe baseline characteristics with or without propensity score weights K Yoshida, A Bartel, JJ Chipman R package version 0.12. 0, 2020 | 147 | 2020 |
| Association between combined TMPRSS2: ERG and PCA3 RNA urinary testing and detection of aggressive prostate cancer MG Sanda, Z Feng, DH Howard, SA Tomlins, LJ Sokoll, DW Chan, ... JAMA oncology 3 (8), 1085-1093, 2017 | 145 | 2017 |
| Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer BS Hoppe, JM Michalski, NP Mendenhall, CG Morris, RH Henderson, ... Cancer 120 (7), 1076-1082, 2014 | 110 | 2014 |
| Association of treatment with metformin vs sulfonylurea with major adverse cardiovascular events among patients with diabetes and reduced kidney function CL Roumie, J Chipman, JY Min, AJ Hackstadt, AM Hung, RA Greevy, ... Jama 322 (12), 1167-1177, 2019 | 84 | 2019 |
| Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice JJ Chipman, MG Sanda, RL Dunn, JT Wei, MS Litwin, CM Crociani, ... The Journal of urology 191 (3), 638-645, 2014 | 77 | 2014 |
| Association of SPOP mutations with outcomes in men with de novo metastatic castration-sensitive prostate cancer U Swami, PI Velho, R Nussenzveig, J Chipman, VS Santos, S Erickson, ... European urology 78 (5), 652-656, 2020 | 65 | 2020 |
| Uncertainty and perception of danger among patients undergoing treatment for prostate cancer MW Kazer, DE Bailey Jr, J Chipman, SP Psutka, J Hardy, L Hembroff, ... BJU international 111 (3b), E84-E91, 2013 | 55 | 2013 |
| A roadmap to using randomization in clinical trials VW Berger, LJ Bour, K Carter, JJ Chipman, CC Everett, N Heussen, ... BMC medical research methodology 21, 1-24, 2021 | 50 | 2021 |
| Volumetric and voxel-based morphometry findings in autism subjects with and without macrocephaly ED Bigler, TJ Abildskov, JA Petrie, M Johnson, N Lange, J Chipman, J Lu, ... Developmental neuropsychology 35 (3), 278-295, 2010 | 47 | 2010 |
| Simplifying clinical use of the genetic risk prediction model BRCAPRO S Biswas, P Atienza, J Chipman, K Hughes, AMG Barrera, CI Amos, ... Breast cancer research and treatment 139, 571-579, 2013 | 39 | 2013 |
| Recent BRCAPRO upgrades significantly improve calibration E Mazzola, J Chipman, SC Cheng, G Parmigiani Cancer epidemiology, biomarkers & prevention 23 (8), 1689-1695, 2014 | 33 | 2014 |
| Hospitalization for lactic acidosis among patients with reduced kidney function treated with metformin or sulfonylureas PY Chu, AJ Hackstadt, J Chipman, MR Griffin, AM Hung, RA Greevy Jr, ... Diabetes Care 43 (7), 1462-1470, 2020 | 26 | 2020 |
| Endothelial activation markers as disease activity and damage measures in juvenile dermatomyositis T Kishi, J Chipman, M Evereklian, K Nghiem, M Stetler-Stevenson, ... The Journal of rheumatology 47 (7), 1011-1018, 2020 | 20 | 2020 |
| A two-stage approach to genetic risk assessment in primary care S Biswas, P Atienza, J Chipman, AL Blackford, B Arun, K Hughes, ... Breast cancer research and treatment 155, 375-383, 2016 | 19 | 2016 |
| Validation of an algorithm to identify heart failure hospitalisations in patients with diabetes within the veterans health administration CA Presley, JY Min, J Chipman, RA Greevy, CG Grijalva, MR Griffin, ... BMJ open 8 (3), e020455, 2018 | 18 | 2018 |
| Providing access to risk prediction tools via the HL7 XML-formatted risk web service J Chipman, B Drohan, A Blackford, G Parmigiani, K Hughes, P Bosinoff Breast cancer research and treatment 140, 187-193, 2013 | 18 | 2013 |
| Simpson's paradox in the integrated discrimination improvement J Chipman, D Braun Statistics in medicine 36 (28), 4468-4481, 2017 | 17 | 2017 |
| A real-world analysis of the use of systemic therapy in malignant pleural mesothelioma and the differential impacts on overall survival by practice pattern K Kerrigan, Y Jo, J Chipman, B Haaland, S Puri, W Akerley, S Patel JTO Clinical and Research Reports 3 (3), 100280, 2022 | 14 | 2022 |
| Expanded Prostate Cancer Index Composite-26 (EPIC-26) online: validation of an internet-based instrument for assessment of health-related quality of life after treatment for … DJ Einstein, D Patil, J Chipman, MM Regan, K Davis, CM Crociani, ... Urology 127, 53-60, 2019 | 14 | 2019 |
